Transdermal patches: Design and current approaches to painless drug delivery

被引:135
作者
Al Hanbali, Othman A. [1 ,2 ]
Khan, Haji Muhammad Shoaib [3 ]
Sarfraz, Muhammad [4 ,5 ]
Arafat, Mosab [4 ]
Ijaz, Shakeel [3 ]
Hameed, Abdul [3 ]
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Nablus West Bank, Dana Pharmaceut Factory, Zawata Rd, Nablus, Palestine
[3] Islamia Univ Bahawalpur, Fac Pharm & Alternat Med, Dept Pharm, Bahawalpur, Pakistan
[4] Al Ain Univ Sci & Technol, Coll Pharm, POB 64141, Al Ain, U Arab Emirates
[5] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2E1, Canada
关键词
transdermal patch; transdermal drug delivery; polymer matrix; adhesives; skin formulation; CHEMICAL PENETRATION ENHANCERS; PRESSURE-SENSITIVE ADHESIVES; IN-VITRO EVALUATION; HPMC GEL; SKIN PENETRATION; STRATUM-CORNEUM; SOLVENT SYSTEM; ETHANOL-WATER; BILE-SALT; RAT SKIN;
D O I
10.2478/acph-2019-0016
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Use of transdermal patches can evade many issues associated with oral drug delivery, such as first-pass hepatic metabolism, enzymatic digestion attack, drug hydrolysis and degradation in acidic media, drug fluctuations, and gastrointestinal irritation. This article reviews various transdermal patches available in the market, types, structural components, polymer role, and the required assessment tools. Although transdermal patches have medical applications for smoking cessation, pain relief, osteoporosis, contraception, motion sickness, angina pectoris, and cardiac disorders, advances in formulation development are ongoing to make transdermal patches capable of delivering more challenging drugs. Transdermal patches can be tailored and developed according to the physicochemical properties of active and inactive components, and applicability for long-term use. Therefore, a number of chemical approaches and physical techniques for transdermal patch development are under investigation.
引用
收藏
页码:197 / 215
页数:19
相关论文
共 99 条
[1]
Skin models for the testing of transdermal drugs [J].
Abd, Eman ;
Yousef, Shereen A. ;
Pastore, Michael N. ;
Telaprolu, Krishna ;
Mohammed, Yousuf H. ;
Namjoshi, Sarika ;
Grice, Jeffrey E. ;
Roberts, Michael S. .
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 :163-176
[2]
Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study [J].
Abu Hashim, Irhan Ibrahim ;
El-Magd, Noha Fawzy Abo ;
El-Sheakh, Ahmed Ramadan ;
Hamed, Mohammed Fawzy ;
Abd El-Gawad, Abd El-Gawad Helmy .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 :1059-1079
[3]
A novel transdermal patch incorporating meloxicam: In vitro and in vivo characterization [J].
Ah, Young-Chang ;
Choi, Jin-Kyu ;
Choi, Yang-Kyu ;
Ki, Han-Moi ;
Bae, Joon-Ho .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 385 (1-2) :12-19
[4]
Ahmed A., 2010, INT J BIOMED ADV RES, V2, P38, DOI [10.7439/ijbar.v2i1.21, DOI 10.7439/IJBAR.V2I1.21]
[5]
Al Hanbali OA, 2018, PAK J PHARM SCI, V31, P345
[6]
Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil [J].
Al-Saidan, SM ;
Krishnaiah, YSR ;
Chandrasekhar, DV ;
Lalla, JK ;
Rama, B ;
Jayaram, B ;
Bhaskar, P .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2004, 17 (06) :310-320
[7]
Approaches for breaking the barriers of drug permeation through transdermal drug delivery [J].
Alexander, Amit ;
Dwivedi, Shubhangi ;
Ajazuddin ;
Giri, Tapan K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Tripathi, Dulal Krishna .
JOURNAL OF CONTROLLED RELEASE, 2012, 164 (01) :26-40
[8]
Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[9]
Anitha P, 2011, PAK J PHARM SCI, V24, P155
[10]
[Anonymous], THESIS